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Picornaviruses have evolved elaborate strategies to subvert host translation. In this issue of Cell Host and
Microbe, Ho et al. (2011) report that enterovirus infection induces the synthesis of a transcription factor
that enhances the synthesis of microRNA-141, which suppresses translation of the cap-binding protein,
eIF4E, mRNA to inhibit cap-dependent translation.Viruses are unable to carry the huge
amount of genetic information needed
to synthesize ribosomal proteins and
RNA. Thus, viruses have developed
numerous ways to compete for the host
translation machinery. All host mRNAs
contain 50 terminal cap structures. These
terminal cap structures bind the cap-
binding protein, eIF4E, which is part of
a larger complex, termed eIF4F, which
includes the RNA helicase eIF4A and
the multisubunit complex eIF4G (Fig-
ure 1A). The eIF4F complex is thought
to recruit the 40S ribosomal subunit to
the mRNA. The 40S subunit scans the
mRNA in a 50-to-30 direction until an
appropriate start codon is encountered,
at which point the 60S subunit joins and
polypeptide synthesis begins (Sonenberg
and Hinnebusch, 2009). Picornaviral
mRNAs, on the other hand, do not contain
50 cap structures. A large RNA structure
in the viral 50 noncoding region, termed
internal ribosome entry site (IRES),
recruits the 40S subunit. Consequently,
IRES-mediated association of 40S
subunits does not require eIF4E in most,
but not all, cases (Belsham and Sonen-
berg, 1996). To effectively compete
for host ribosomal subunits, picorna-
viruses employ several major strategies
(Figure 1A). (1) For example, poliovirusinfection induces the dephosphorylation
of eIF4E binding proteins (4E-BPs) that
sequester eIF4E, resulting in the inhibition
of cap-dependent translation (Gingras
et al., 1996). (2) Poliovirus-encoded
protease 2A cleaves eIF4G. The proteol-
ysis of eIF4G does not cause but
enhances the inhibition of cap-dependent
translation of host mRNAs (Gradi et al.,
1998). (3) Both poliovirus-encoded 2A
and 3C proteases cleave the polyadeno-
sine binding protein (PABP), leading to
reduced translation of both host and viral
mRNAs late in infected cells (Kuyumcu-
Martinez et al., 2004). (4) 2A and 3C prote-
ases cleave host transcription factors,
limiting newly transcribed mRNA species
that are preferentially translated (Yala-
manchili et al., 1997). Thus, it has been
assumed that picornavirus-induced cyto-
pathic effects can be explained by the
inhibition of transcription and translation
of host genes.
In this issue, Ho and colleagues
challenge this view by presenting the
remarkable finding that enterovirus 71
(EV71) infection results in the transcrip-
tional induction of the early growth
response 1 (EGR1) gene, a host transcrip-
tion factor. EGR1 protein activates the
transcription of a microRNA that re-
presses eIF4E mRNA translation, leadingto decreased abundance of eIF4E protein
(Figure 1B).
The study by Ho et al. started with
a straightforward question: Do microRNA
abundances change during EV71 infec-
tion of human rhabdomyosarcoma cells?
Because enterovirus infection inhibits
host-cell transcription, one would expect
downregulation of microRNAs or unal-
tered change in abundance of long-lived
microRNAs in infected cells. While 248
microRNAs followed that predicted
pattern, two microRNAs, miR-141 and
miR-146a, were upregulated more than
15-fold in EV71-infected cells compared
to uninfected cells (Ho et al., 2011).
Aided by target prediction programs
andverified in reporter-expressionassays,
the authors showed that miR-141 targets
eIF4E mRNA, leading to decreased
abundance of eIF4E. Sequestration of
miR-141 by anti-sense RNAs, so-called
antagomirs, effectively rescued eIF4E
protein abundance. This phenotype was
completely reversed by siRNA-mediated
depletion of eIF4E mRNA, suggesting
that miR-141 directly regulates eIF4E
mRNA expression (Ho et al., 2011). Inter-
estingly, treatment of infected cells with
miR-141 antagomir leads to a 1000-fold
decrease in virus production at a time
when eIF4G was completely cleaved9, January 20, 2011 ª2011 Elsevier Inc. 5
Figure 1. Picornavirus Strategies to Inhibit Cap-dependent Translation
(A) Picornavirus infection results in sequestration of eIF4E and cleavage of factors eIF4G and PABP. See text for details.
(B) Infection by enterovirus 71 (EV71), poliovirus 3 (PV3) or coxsackievirus B3 (CVB3) upregulates the transcription factor, EGR1, which results in increased
expression of primary miR-141 transcript and mature miR-141. Mature miR-141 binds to the 30 UTR of eIF4E mRNA and suppresses protein synthesis.
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that EV71 hasdevelopedmultiple, additive
ways to obliterate cap-mediated transla-
tion and that viral propagation is greatly
enhanced when eIF4E abundance is low.
Several open questions remain. Other
predicted targets for miR-141 include the
cytoplasmic polyadenylation element
binding protein, CPEB (Ho et al., 2011),
which promotes elongation of the poly-
adenosine tail ofmRNAs.Does downregu-
lation of CPEB contribute to the efficiency
of virus propagation? Furthermore, it is
known that the hepatitis A virus IRES
requires eIF4E for its activity (Ali et al.,
2001). Does miR-141-induced depletion
of eIF4E abundance lead to lower virus
yield in Hepatitis A virus-infected cells?
One of the fascinating findings in this
study is the upregulation of the transcrip-
tion factor EGR1 during EV71 infection.
Both EGR1 RNA and protein levels were
dramatically increased upon enterovirus
infection, suggesting that transcription
and translation of the EGR1 gene can
escape virus-mediated inhibition of these
pathways (Ho et al., 2011). What triggers6 Cell Host & Microbe 9, January 20, 2011 ª2EGR1 expression? Is virus entry sufficient
for the induction of EGR1 transcription,
or is expression of the viral genome a
prerequisite for EGR1 transcription? How
does EGR1 activate miR-141 transcription
during EV71 infection? Is the rate of pre-
miR-141 processing to yield mature miR-
141 affected? pri-miR-141 is predicted to
encode a second microRNA, miR-200c.
The authors show that EGR1 induces
expression of both miR-141 and miR-
200c (Ho et al., 2011). It is curious that
although both microRNAs are present on
the primary transcript, only mature miR-
141 levels were dramatically increased.
Does virus infection modulate posttran-
scriptional processing or turnover of these
microRNAs? miR-200c and miR-141 have
only four nucleotide differences from each
other, only one of which is in the seed
sequence. Thus, it is very likely that both
microRNAs were sequestered by miR-
141 antagomirs, which may explain the
enhanced effects of antagomirs compared
to siRNAs on virus growth.
In conclusion, Ho et al. have revealed
yet another mechanism bywhich picorna-011 Elsevier Inc.viruses can effectively shut down capped
host mRNA translation. Once again,
microRNAs seem to take center stage in
regulating viral-host pathogenesis. Inter-
estingly, eIF4E is upregulated in a variety
of cancers (Wendel et al., 2004), suggest-
ing that antagomirs directed against
miR-141may be explored as therapeutics
for cancers as well as enterovirus
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